DUBLIN, November 8, 2013 /PRNewswire/ --
Research and Markets
( http://www.researchandmarkets.com/research/tfh2m9/aptamers_market) has announced the addition of the "Global Aptamers Market Technology Trend Analysis Market Report 2013-2018" report to their offering.
The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018.
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
Aptamers existed alongside antibodies for two decades, but their market potential was not utilized to even a fraction of the same degree. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.
Though there are just approximately 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups focused on the diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a large number of patents granted and filed for this technology.
As well as a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.
Furthermore this report assesses the investor climate by tracking the complete investor network and collecting data on funds/grants and investments made in aptamers. Insights on current and future technological investment trends have also been discussed. The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater market value during the forecast period.
Scope of the Report
- Drug discovery
- Biomarker discovery
- Research applications
By Aptamer Type
- Nucleic acid aptamers
- Peptide aptamers
Key Topics Covered:
2 Executive Summary
3 Aptamers - Technology Landscape Analysis
4 Aptamers - Market Landscape Analysis
5 Technology Investment Potential
6 Aptamers - Technology Adoption And Development Potential
7 Aptamers Competitive Landscape
8 Intellectual Property And Research Strength Analysis
9 Analyst Insights And Recommendations
10 Company Profiles
- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
For more information visit http://www.researchandmarkets.com/research/tfh2m9/aptamers_market
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved